Clinical Study

Microscopic Evaluation, Molecular Identification, Antifungal Susceptibility, and Clinical Outcomes in Fusarium, Aspergillus and, Dematiaceous Keratitis

Table 2

In vitro susceptibility of Fusarium, Aspergillus, and Dematiaceous isolates to antifungal agents.

Isolate (number)Agent, G-MIC (range)
NatamycinAmphotericin BFluconazoleItraconazole

Fusarium solani 29.3 (8–128)6.3 (1–32)128 (≥128)113.7 (64–128)
Fusarium delphinoides 12 (8–16)12 (8–16)128 (≥128)128 (≥128)
Aspergillus flavus 32 (32)0.35 (0.2–0.5)128 (≥128)1.5 (1–2)
Aspergillus terreus 13.3 (8–16)2.5 (1–3)26.6 (16–32)0.25 (0.25)
Aspergillus niger 80.0612864
Aspergillus tamarii 640.25≥1280.25
Aspergillus tubingensis 82320.25
Aspergillus sydowii 44≥128≥128
Aspergillus versicolor 42320.25
Curvularia lunata 12.5 (2–32)16 (0.25–32)128 (≥128)128 (≥128)
Exherohelum rostratum 2 (2–4)1 (0.5–2)32 (32)0.25 (0.25–0.5)
Cladorrhinum bulbilossum 0.0640.0640.320.016
Lasiodiplodia theobromae 0.0640.0640.320.016
Papulaspora spp. 0.0640.0640.320.016

Geometric mean of MIC.